These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19563346)

  • 1. Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.
    White JR; Leppik IE; Beattie JL; Walczak TS; Tran TA; Rarick JO; Vaher P
    Epilepsia; 2009 Nov; 50(11):2390-6. PubMed ID: 19563346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Felbamate monotherapy for partial-onset seizures: an active-control trial.
    Faught E; Sachdeo RC; Remler MP; Chayasirisobhon S; Iragui-Madoz VJ; Ramsay RE; Sutula TP; Kanner A; Harner RN; Kuzniecky R
    Neurology; 1993 Apr; 43(4):688-92. PubMed ID: 8469323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial.
    Dodson WE
    Epilepsia; 1993; 34 Suppl 7():S18-24. PubMed ID: 8243374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felbamate monotherapy: controlled trial in patients with partial onset seizures.
    Sachdeo R; Kramer LD; Rosenberg A; Sachdeo S
    Ann Neurol; 1992 Sep; 32(3):386-92. PubMed ID: 1416808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice.
    Borowicz KK; Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Oct; 45(10):1176-83. PubMed ID: 15461671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of phenytoin and carbamazepine in patients receiving felbamate.
    Wagner ML; Graves NM; Marienau K; Holmes GB; Remmel RP; Leppik IE
    Epilepsia; 1991; 32(3):398-406. PubMed ID: 1904346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Felbamate.
    Leppik IE
    Epilepsia; 1995; 36 Suppl 2():S66-72. PubMed ID: 8784215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felbamate monotherapy: implications for antiepileptic drug development.
    Theodore WH; Albert P; Stertz B; Malow B; Ko D; White S; Flamini R; Ketter T
    Epilepsia; 1995 Nov; 36(11):1105-10. PubMed ID: 7588454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felbamate in the treatment of partial-onset seizures.
    Bourgeois BF
    Epilepsia; 1994; 35 Suppl 5():S58-61. PubMed ID: 8039474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and pharmacokinetics of monotherapy felbamate doses of 1,200-6,000 mg/day in subjects with epilepsy.
    Sachdeo R; Narang-Sachdeo SK; Shumaker RC; Perhach JL; Lyness WH; Rosenberg A
    Epilepsia; 1997 Aug; 38(8):887-92. PubMed ID: 9579889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model.
    Luszczki JJ; Andres-Mach MM; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2007 Apr; 48(4):806-15. PubMed ID: 17284299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felbamate in the treatment of Lennox-Gastaut syndrome.
    Jensen PK
    Epilepsia; 1994; 35 Suppl 5():S54-7. PubMed ID: 8039473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Felbamate in the treatment of refractory partial-onset seizures.
    Jensen PK
    Epilepsia; 1993; 34 Suppl 7():S25-9. PubMed ID: 8243375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Felbamate in refractory partial epilepsy.
    Canger R; Vignoli A; Bonardi R; Guidolin L
    Epilepsy Res; 1999 Mar; 34(1):43-8. PubMed ID: 10194111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Felbamate in an adult population with severe refractory epilepsy.
    Kearney H; Delanty N
    Ir Med J; 2009; 102(10):326-8. PubMed ID: 20108801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model.
    Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2005 Mar; 46(3):344-55. PubMed ID: 15730531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felbamate: a clinical trial for complex partial seizures.
    Theodore WH; Raubertas RF; Porter RJ; Nice F; Devinsky O; Reeves P; Bromfield E; Ito B; Balish M
    Epilepsia; 1991; 32(3):392-7. PubMed ID: 2044501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Felbamate: a long-term study in subjects with refractory epilepsy].
    De Romanis F; Sopranzi N
    Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Felbamate.
    Pellock JM
    Epilepsia; 1999; 40 Suppl 5():S57-62. PubMed ID: 10530695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.